Rapamycin in combination with donor-specific CD4+CD25+Treg cells amplified in vitro might be realize the immune tolerance in clinical organ transplantation.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cellular Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cellimm.2010.05.014PMID 20580348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulatory T Cells in Transplantation

  2011cited by this paper
• Mammalian Target of Rapamycin Inhibition and Alloantigen-Specific Regulatory T Cells Synergize To Promote Long-Term Graft Survival in Immunocompetent Recipients

  2009cited by this paper
• Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

  2008cited by this paper
• Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells

  2008cited by this paper
• Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells.

  2008cited by this paper
• Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN‐γ+ blood lymphocytes in kidney transplant recipients with good long‐term graft outcome

  2008cited by this paper
• Regulatory T cells: hypes and limitations.

  2008cited by this paper
• CD4+CD25+ Regulatory T Cells in Transplantation: Progress, Challenges and Prospects

  2007cited by this paper
• Immune tolerance: mechanisms and application in clinical transplantation

  2007cited by this paper
• Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin1

  2007cited by this paper
• mTOR signalling in human cancer.

  2007cited by this paper
• The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.

  2007cited by this paper
• Contrasting Effects of Cyclosporine and Rapamycin in De Novo Generation of Alloantigen‐Specific Regulatory T Cells

  2007cited by this paper
• mTOR signaling in human cancer

  2007cited by this paper
• Low circulating regulatory T‐cell levels after acute rejection in liver transplantation

  2006cited by this paper
• Late mortality in 679 consecutive liver transplant recipients: the Gothenburg liver transplant experience.

  2006cited by this paper
• Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway

  2006cited by this paper
• Rapamycin-Mediated Enrichment of T Cells with Regulatory Activity in Stimulated CD4+ T Cell Cultures Is Not Due to the Selective Expansion of Naturally Occurring Regulatory T Cells but to the Induction of Regulatory Functions in Conventional CD4+ T Cells1

  2006cited by this paper
• Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation

  2006cited by this paper
• Tolerance is the achievable ‘Holy Grail’ in transplantation

  2006cited by this paper
• Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance.

  2006cited by this paper
• Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.

  2006cited by this paper
• Organ transplantation—how much of the promise has been realized?

  2005cited by this paper
• Immunosuppression--the promise of specificity.

  2005cited by this paper
• Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

  2005cited by this paper
• Regulatory T-cell therapy: is it ready for the clinic?

  2005cited by this paper
• Differential Effect of Calcineurin Inhibitors, Anti-CD25 Antibodies and Rapamycin on the Induction of FOXP3 in Human T Cells

  2005cited by this paper
• Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

  2005cited by this paper
• Low Incidence of Malignancy among Sirolimus/Cyclosporine-Treated Renal Transplant Recipients

  2005cited by this paper
• Transplantation tolerance. A complex scenario awaiting clinical applicability.

  2005cited by this paper
• Two‐year incidence of malignancy in sirolimus‐treated renal transplant recipients: results from five multicenter studies *

  2004cited by this paper
• Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome

  2004cited by this paper
• Rapamycin impairs antigen uptake of human dendritic cells1

  2003cited by this paper
• Regulatory lymphocytes: Regulatory T cells in transplantation tolerance

  2003cited by this paper
• Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells.

  2002cited by this paper
• Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days post-kidney transplantation.

  2002cited by this paper
• In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines

  2002cited by this paper
• Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

  2002cited by this paper
• Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood

  2001cited by this paper
• Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

  2001cited by this paper
• Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood

  2001cited by this paper
• Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

  2001cited by this paper
• A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS

  2001cited by this paper
• Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function

  2001cited by this paper
• Regulating the immune response to transplants. a role for CD4+ regulatory cells?

  2001cited by this paper
• CD4+CD25high Regulatory Cells in Human Peripheral Blood1

  2001cited by this paper
• The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders.

  2000cited by this paper
• Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.

  1999cited by this paper
• RAPAMYCIN, A POTENT IMMUNOSUPPRESSIVE DRUG, CAUSES PROGRAMMED CELL DEATH IN B LYMPHOMA CELLS

  1995cited by this paper
• CD4-positive suppressor cells block allotransplant rejection.

  1995cited by this paper
• Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action

  1990cited by this paper
• INDUCTION OF SUPPRESSOR CELLS BY DONOR‐SPECIFIC BLOOD TRANSFUSIONS AND HEART TRANSPLANTATION IN RATS

  1981cited by this paper
• Suppressor T cells in mice made unresponsive to skin allografts

  1975cited by this paper
• Cell interactions in the induction of tolerance: the role of thymic lymphocytes.

  1970cited by this paper

• Donor-specific HLA Antibodies in Solid Organ Transplantation: Clinical Relevance and Debates

  2019cites this paper
• Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis

  2017cites this paper
• Combined treatment with simvastatin and rapamycin attenuates cardiac allograft rejection through the regulation of T helper 17 and regulatory T cells

  2017cites this paper
• Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches

  2016cites this paper
• Complement component 3 deficiency prolongs MHC-II disparate skin allograft survival by increasing the CD4+ CD25+ regulatory T cells population

  2016cites this paper
• Combining Exosomes Derived from Immature DCs with Donor Antigen-Specific Treg Cells Induces Tolerance in a Rat Liver Allograft Model

  2016cites this paper
• T-regulatory cells in chronic rejection versus stable grafts.

  2015cites this paper
• Anti-CD20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice

  2014cites this paper
• Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia

  2013cites this paper
• CD4+CD25−Nrp1+ T Cells Synergize with Rapamycin to Prevent Murine Cardiac Allorejection in Immunocompetent Recipients

  2013cites this paper
• Interleukin-2 and autoimmune disease occurrence and therapy.

  2012cites this paper
• Current and future challenges in therapy for antibody-mediated rejection.

  2011cites this paper
• Lymphocytes T régulateurs et Transplantation hépatique : modulation de l'activité des lymphocytes T régulateurs CD4+CD25+ par les drogues immunosuppressives

  2011cites this paper